日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Discovery of GBA-16-24 as a highly potent, selective ATR inhibitor for the treatment of FLT3-mutated acute myeloid leukemia.

发现 GBA-16-24 是一种高效、选择性的 ATR 抑制剂,可用于治疗 FLT3 突变的急性髓系白血病。

Li Ping, Ren Haiyan, Lan Xinyan, Li Junfei, Liu Zhi, Liu Huashuo, Zheng Zhijie, Zeng Tianyan, Wang Peili, Sun Mingyang, Xu Lei, Zhang Yanyan, Zhou Yubo, Li Jia, Wang Mingliang, Jiang Kailong

Research Advances on Targets and Mechanisms in Cancers Complicated by Cardiovascular Diseases

心血管疾病并发癌症的靶点和机制研究进展

Li, Jianing; Wang, Peili

Small-molecule targeting BCAT1-mediated BCAA metabolism inhibits the activation of SHOC2-RAS-ERK to induce apoptosis of Triple-negative breast cancer cells.

靶向 BCAT1 介导的 BCAA 代谢的小分子抑制 SHOC2-RAS-ERK 的激活,从而诱导三阴性乳腺癌细胞凋亡。

Huang Ling, Li Guanjun, Zhang Ying, Zhuge Ruishen, Qin Shijie, Qian Jinjun, Chen Ruixing, Kwan Wong Yin, Tang Huan, Wang Peili, Xiao Wei, Wang Jigang

Eupalinolide B inhibits periodontitis development by targeting ubiquitin conjugating enzyme UBE2D3.

Eupalinolide B 通过靶向泛素结合酶 UBE2D3 来抑制牙周炎的发展

Kuang Wenhua, Zhuge Ruishen, Song Ping, Yi Letai, Zhang Shujie, Zhang Ying, Wong Yin Kwan, Chen Ruixing, Zhang Junzhe, Wang Yuanbo, Liu Dandan, Gong Zipeng, Wang Peili, Ouyang Xiangying, Wang Jigang

Dual-targeted N-PMI(plus)@CA nanoplatform for concurrent MDM2 and β-catenin inhibition in p53 wild-type lung adenocarcinoma

双靶向N-PMI(plus)@CA纳米平台可同时抑制p53野生型肺腺癌中的MDM2和β-catenin

Zhao, Ni; You, Weiming; Zheng, Xiaoqiang; Yan, Jin; Wang, Peili; Yao, Yu; He, Wangxiao; Liu, Tianya

Chemoproteomics unveils Sofalcone targeting ribosomal proteins to inhibit protein synthesis in Staphylococcus aureus

化学蛋白质组学揭示索法酮靶向核糖体蛋白以抑制金黄色葡萄球菌的蛋白质合成

Zhou, Lirun; Zhang, Ying; Zhuge, Ruishen; Wu, Liqiong; Chu, Zheng; Ma, Ang; Gao, Peng; Wong, Yin Kwan; Zhang, Junzhe; Peng, Xin; Wang, Peili; Wang, Jigang; Tang, Huan

Bringing p53 Back: A Prion-Powered Attack on Retinoblastoma

p53 的回归:朊病毒对视网膜母细胞瘤的攻击

Ma, Yuyan; Yan, Siqi; You, Weiming; Wang, Peili; He, Wangxiao; Yao, Yu; Zheng, Xiaoqiang

PARP inhibitor augments anti-tumor efficacy of DNMT inhibitor by inducing senescence in cholangiocarcinoma.

PARP抑制剂通过诱导胆管癌细胞衰老来增强DNMT抑制剂的抗肿瘤功效

Wang Peili, Xiao Rong, Chen Jianfeng, Guan Peiyong, Heng Hong Lee, Liu Lizhen, Wang Yali, Zeng Xian, Zhong Guixiang, Hao Jing, Gao Jiuping, Chan Jason Yongsheng, Dima Simona, Ong Choon Kiat, Teh Bin Tean, Li Mei, Hong Jing Han, Tan Jing

Comprehensive single-cell pan-cancer atlas unveils IFI30+ macrophages as key modulators of intra-tumoral immune dynamics

全面的单细胞泛癌图谱揭示IFI30+巨噬细胞是肿瘤内免疫动力学的关键调节因子

Jiang, Lihe; Wang, Peili; Hou, Yixuan; Chen, Jingying; Li, Hua

Disrupting β-Catenin/BCL9 interaction with a peptide prodrug boosts immunotherapy in colorectal cancer.

利用肽前药破坏β-catenin/BCL9相互作用可增强结直肠癌的免疫疗法

Wang Peili, Shang Xiao, Wang Jinmei, You Weiming, Qu Shoufei, Yao Yu, Zheng Xiaoqiang